[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
April 13, 1994

Lipoprotein(a) and Risk of Myocardial Infarction

Author Affiliations

Universität Munich Munich, Germany

JAMA. 1994;271(14):1077. doi:10.1001/jama.1994.03510380033020

To the Editor.  —The article by Ridker et al1 describing similar Lp(a) concentrations in patients with MI and matched controls is very welcome since prospective studies on this subject are sparse.2,3 In the article and in the accompanying Editorial,4 some possible reasons for the discrepant results compared with numerous (retrospective) studies are listed, but we would like to draw the attention to two further aspects.Despite similar apo(a) isoform and phenotype distribution we were able to detect 53% lower Lp(a) concentrations in patients with hypertriglyceridemia (>12.93 mmol/L [500 mg/ dL], n=147) compared with controls (n=404, P<.0001). Concentrations of triglycerides and Lp(a) were negatively correlated in hypertriglyceridemic patients (r=-0.22, P<.01).5 In the study by Ridker et al, triglyceride concentrations are not given, but the cases had markedly lower high-density lipoprotein (HDL) cholesterol values compared with the controls. Because of the known negative correlation, this

First Page Preview View Large
First page PDF preview
First page PDF preview